{"nctId":"NCT01397448","briefTitle":"Prevention of Recurrent Gastric or Duodenal Ulcers Caused by Low-dose Aspirin With Rabeprazole (E3810) Treatment (Planetarium Study)","startDateStruct":{"date":"2011-07"},"conditions":["Gastric or Duodenal Ulcers Caused by Low-dose Aspirin"],"count":472,"armGroups":[{"label":"E3810 5 mg","type":"EXPERIMENTAL","interventionNames":["Drug: E3810"]},{"label":"E3810 10 mg","type":"EXPERIMENTAL","interventionNames":["Drug: E3810"]},{"label":"Teprenone 150 mg","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Teprenone"]}],"interventions":[{"name":"E3810","otherNames":[]},{"name":"E3810","otherNames":[]},{"name":"Teprenone","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria\n\n* Require long-term administration of low-dose aspirin (81 mg/day or 100 mg/day)\n* Confirmed to have a history of gastric or duodenal ulcer\n\nExclusion Criteria\n\n-Confirmed to have acute gastro duodenal mucosal lesions, gastric or duodenal ulcer, or upper gastrointestinal (esophagus, stomach, duodenum) bleeding Confirmed to have reflux esophagitis or long segment Barrett's esophagus","healthyVolunteers":false,"sex":"ALL","minimumAge":"20 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"SECONDARY","title":"Cumulative Incidence of Bleeding Ulcers","description":null,"paramType":"NUMBER","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"0","spread":null},{"groupId":"OG002","value":"4.6","spread":null}]}]}]},{"type":"PRIMARY","title":"Cumulative Recurrent Rates of Gastric or Duodenal Ulcers","description":"Mucosal injuries with a white coat measuring 3 mm in diameter will be diagnosed as ulcers. When ulcer is confirmed by endoscopic examination during the trial, it will be regarded as recurrence of ulcer and the trial will be discontinued for the patient involved.","paramType":"NUMBER","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2.8","spread":null},{"groupId":"OG001","value":"1.4","spread":null},{"groupId":"OG002","value":"21.7","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":10,"n":156},"commonTop":["Nasopharyngitis","Constipation","Diarrhoea","Upper respiratory tract infection","Pharyngitis"]}}}